Results 61 to 70 of about 187,468 (310)

Optimizing Hydroxychloroquine Blood Levels and Long‐Term Hydroxychloroquine Intake Could Lower Atherosclerotic Cardiovascular Disease Risk and Prevent Polypharmacy in Systemic Lupus Erythematosus

open access: yesArthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) is the cornerstone of systemic lupus erythematosus (SLE) management with benefits extending beyond SLE control, including protection against atherosclerotic cardiovascular disease (ASCVD). Although HCQ blood levels reflect recent exposure and long‐term intake reflects medication adherence, the impact of longitudinal ...
Shivani Garg   +5 more
wiley   +1 more source

Microvascular Damage Is Associated With Carotid Wall Structural Changes in Systemic Sclerosis: A Capillaroscopy and Ultrasound‐Based Observational Study

open access: yesArthritis Care &Research, EarlyView.
Objective Systemic sclerosis (SSc) is characterized by cardiovascular risk excess not fully explained by traditional factors. Whether the severity of microvascular damage correlates with structural subclinical atherosclerosis remains unclear. We investigated the relationship between nailfold videocapillaroscopy (NVC) abnormalities and carotid ...
Eugenio Capparelli   +13 more
wiley   +1 more source

Short- and Long-Term Statin Persistence and Determinants in Patients Initiating Statin Therapy

open access: yesMedeniyet Medical Journal
Objective: Despite the established efficacy of statins in reducing major cardiovascular events and mortality, rates of statin persistence remain low.
Mehmet UZUNLULU   +4 more
doaj   +1 more source

Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection

open access: yes, 2017
Background & Aims: Several animal studies have shown that statins can inhibit the progression of cirrhosis; however, few clinical studies have been conducted. Previous studies have indicated that statins can prevent the progression of hepatic fibrosis in
陳保中;陳美志   +1 more
core   +1 more source

Baseline characteristics of statin users versus statin non-users.

open access: yes, 2021
Baseline characteristics of statin users versus statin non-users.
Albert Danso Osei (11419023)   +13 more
core   +1 more source

Elevated Liver Enzymes Is Not an Impediment to Allopurinol Dose Escalation: An Observational Cohort Study

open access: yesArthritis Care &Research, EarlyView.
Objective Routine liver enzyme monitoring is advocated for while on allopurinol, but supporting guidance is lacking. We assessed the incidence and factors associated with elevated liver enzyme levels in patients with gout commenced on allopurinol. Methods One hundred and fifty patients with gout and normal baseline serum aminotransferases initiated on ...
May Shuen Tang   +4 more
wiley   +1 more source

Statin Use Among Women and Men Following Coronary Artery Bypass Surgery

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Limited data exist on sex differences in guideline‐recommended statin therapy for secondary prevention after coronary artery bypass surgery (CABG).
Sigrid Sandner   +11 more
doaj   +1 more source

Statin-induced myopathy associated with atorvastatin therapy in the elderly patient. Clinical case

open access: yes, 2021
Statins are widely used in patients with cardiovascular disorders. However, the issue of the feasibility of prescribing the high-dose and medium-dose statins to elderly patients remains a matter of discussion.
Irina S. Komarova   +4 more
core   +1 more source

Prevalence of Dietary Supplement Use and Potential Medication Interactions Among Adults With Systemic Lupus Erythematosus

open access: yesArthritis Care &Research, EarlyView.
Objective The aim of this study was to characterize the prevalence and correlates of dietary supplement use, identify commonly used supplements, and evaluate potential supplement–medication interactions among adults with systemic lupus erythematosus (SLE).
Sarah L. Patterson   +7 more
wiley   +1 more source

Therapeutic inertia in statin therapy for secondary prevention after percutaneous coronary intervention: a nationwide population-based cohort study

open access: yesBMC Cardiovascular Disorders
Background Therapeutic inertia is defined as the failure to provide guideline-directed therapy and is a barrier to achieving optimal clinical outcomes.
Young-Hoon Seo   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy